Primary stroke prevention. Medical therapy versus revascularization

Marc P. Bonaca, Joshua A. Beckman

Research output: Contribution to journalReview articlepeer-review


Asymptomatic carotid-artery atherosclerotic vascular disease identifies patients at heightened risk of major adverse cardiovascular events including ischemic stroke. Observational and registry analyses demonstrate that this risk extends beyond that attributable to carotid atherosclerosis itself and includes events manifesting in other vascular territories, such as myocardial infarction. However, randomized trials aimed specifically at treating carotid stenosis have shown benefit in terms of reducing ischemic stroke in appropriately selected patients. Therefore, the approach to primary prevention in patients with stable carotid disease must include a comprehensive strategy to reduce cerebrovascular-specific and overall cardiovascular risk through lifestyle changes and intensive medical therapies.

Original languageEnglish (US)
Pages (from-to)1-11
Number of pages11
JournalInterventional Cardiology Clinics
Issue number1
StatePublished - Jan 2014
Externally publishedYes


  • Asymptomatic carotid disease
  • Atherosclerotic vascular disease
  • Carotid artery disease
  • Carotid stenosis
  • Stroke prevention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Primary stroke prevention. Medical therapy versus revascularization'. Together they form a unique fingerprint.

Cite this